Skip to content

Medical-device intelligence

DHN: Antinuclear Antibody, Indirect Immunofluorescent, Antigen, Control

FDA product code DHN: Antinuclear Antibody, Indirect Immunofluorescent, Antigen, Control. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
DHN
FDA device name
Antinuclear Antibody, Indirect Immunofluorescent, Antigen, Control
Device class
2
Regulation number
866.5100
Medical specialty
Immunology
Review panel
IM

The source does not provide a definition for this entry. Consult the FDA classification and regulation reference for further detail.

Explore immunology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

110 clearance records and 7 recall records in the covered releases, across 65 source company names and 1 product codes. Dated history runs from Jul 20, 1976 to Apr 29, 2022.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

117 matching records
Device / recordCompany in FDA recordSourceSource date
LIQUICHEK ANA CONTROL SET, POSITIVE: HOMOGENEOUS, SPECKLED, CENTROMERE AND NUCLEOLAR PATTERNS, CATALOG #131K024230 · DHNBio-Rad510(k)Jan 15, 2003FDA decision date
LIQUICHEK ANTI-MITOTIC SPINDLE PATTERN CONTROL, POSITIVE, CATALOG #118K024231 · DHNBio-Rad510(k)Jan 13, 2003FDA decision date
VISIQUANT ANTI-NUCLEAR ANTIBODY TEST SYSTEMK022800 · DHNHyperion, Inc.510(k)Nov 25, 2002FDA decision date
HYPERION VISIQUANT ANA TEST KITK013213 · DHNHyperion, Inc.510(k)Jun 4, 2002FDA decision date
POLYTITER SYSTEMK012163 · DHNPolymedco, Inc.510(k)Aug 20, 2001FDA decision date
HEP-2 ANA TEST SYSTEM WITH IF-AIM TECHNOLOGYK001556 · DHNThe Binding Site, Ltd.510(k)Aug 21, 2000FDA decision date
INDIRECT FLUORESCENCE ASSAY FOR ANTI-NUCLEAR ANTIBODIES IGG ANTIBODYK990915 · DHNStellar Bio Systems, Inc.510(k)Apr 21, 1999FDA decision date
HEP-2000 COLORZYME ANA-RO TEST SYSTEM, MODEL 4200-ROK983924 · DHNImmuno Concepts, Inc.510(k)Dec 18, 1998FDA decision date
LIQUICHEK ANA CONTROL, CENTROMERE PATTERN, MODEL 203K984397 · DHNBio-Rad510(k)Dec 18, 1998FDA decision date
LIQUICHEK ANA CONTROL, HOMOGENEOUS PATTERN, MODEL 201K984398 · DHNBio-Rad510(k)Dec 18, 1998FDA decision date
LIQUICHEK ANA CONTROL, NUCLEOLAR PATTERN, MODEL 204K984399 · DHNBio-Rad510(k)Dec 18, 1998FDA decision date
LIQUICHEK ANA CONTROL, SPECKLED PATTERN, MODEL 202K984400 · DHNBio-Rad510(k)Dec 18, 1998FDA decision date
HEP-2000 FLUORESCENT ANA-RO TEST SYSTEMK972145 · DHNImmuno Concepts, Inc.510(k)Feb 24, 1998FDA decision date
IFA HEP2 KIT FOR THE DETECTION OF ANTINUCLEAR ANTIBODIESK970198 · DHNScimedx Corp.510(k)Feb 20, 1997FDA decision date
MICRO21 WITH NDNAK964165 · DHNTriangle Biomedical Sciences, Inc.510(k)Jan 3, 1997FDA decision date
HEMAGEN ENA DSDNA KIT (EIA METHOD)K962276 · DHNHemagen Diagnostics, Inc.510(k)Dec 5, 1996FDA decision date
HEP-2000 COLORZYME ANA-RO TEST SYSTEMK950979 · DHNImmuno Concepts, Inc.510(k)Jun 1, 1995FDA decision date
HEP-2000 FLUORESCENT ANA-RO TEST SYSTEMK944096 · DHNImmuno Concepts, Inc.510(k)Nov 21, 1994FDA decision date
HEP-2 ANTINUCLEAR ANTIBODY TEST SYSTEMK926114 · DHNTissue Culture Biotec, Inc.510(k)May 20, 1993FDA decision date
DIASTAT ANTI-JO-1 KITK912292 · DHNShield Diagnostics, Ltd.510(k)Jul 30, 1991FDA decision date
HEMAGEN ENA [JO-I] KITK902139 · DHNHemagen Diagnostics, Inc.510(k)May 18, 1990FDA decision date
NOVA LITE(TM) ANA KSLK901596 · DHNInova Diagnostics, Inc.510(k)May 2, 1990FDA decision date
NOVA LITE(TM) ANA MKK901595 · DHNInova Diagnostics, Inc.510(k)Apr 26, 1990FDA decision date
ANTINUCLEAR ANTIBODY (ANA) TEST SYSTEMK897025 · DHNZeus Scientific, Inc.510(k)Jan 2, 1990FDA decision date
ANA ANTISERA CONTROL KITK894659 · DHNLipogen, Inc.510(k)Sep 21, 1989FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗